Publications by authors named "Mark A Belger"
Article Synopsis
- - The study focused on comparing the effectiveness and safety of a treatment combination involving sintilimab, pemetrexed, and platinum against other FDA-approved immune checkpoint inhibitor (ICI) therapies for patients with advanced non-small-cell lung cancer.
- - Results showed sintilimab + pemetrexed + platinum led to better progression-free survival than certain ICI combinations but had similar overall survival rates and response rates when compared to others, indicating comparable efficacy.
- - While sintilimab combined with chemotherapy had a higher incidence of severe side effects than some alternatives, it did not significantly differ in safety from other ICI combinations, suggesting it may be a viable treatment option.
Objective: To compare the incidence and persistence of tardive dyskinesia between patients diagnosed with schizophrenia (ICD-10 and/or DSM-IV) who were treated with second-generation antipsychotics and first-generation antipsychotics in routine clinical practice.
Method: The European Schizophrenia Outpatient Health Outcomes (SOHO) study is a 3-year, prospective, observational study. Each country had a start date for patient enrollment before October 2000.
An analysis of all pediatric cadaveric renal transplant recipients in the UK and Eire was undertaken to review the outcomes of pediatric cadaveric renal transplantation and to consider the implications for organ allocation procedures for pediatric recipients. Factors influencing the outcome of 1,252 pediatric cadaveric renal transplants in the UK and Eire in the 10-yr period from 1 January 1986 to 31 December 1995 were analyzed by Cox proportional hazards regression, including analysis of four distinct post-transplant epochs (0-3 months, 3-12 months, 12-36 months, and beyond 36 months). At the time of analysis (December 2000), 113 (11%) recipients had died and 47% of grafts had failed.
View Article and Find Full Text PDF